Literature DB >> 22859606

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT.

Edus H Warren1, Xinyi Cindy Zhang, Shuying Li, Wenhong Fan, Barry E Storer, Jason W Chien, Michael J Boeckh, Lue Ping Zhao, Paul J Martin, John A Hansen.   

Abstract

The outcome of allogeneic hematopoietic cell transplantation is influenced by donor/recipient genetic disparity at loci both inside and outside the MHC on chromosome 6p. Although disparity at loci within the MHC is the most important risk factor for the development of severe GVHD, disparity at loci outside the MHC that encode minor histocompatibility (H) antigens can elicit GVHD and GVL activity in donor/recipient pairs who are otherwise genetically identical across the MHC. Minor H antigens are created by sequence and structural variations within the genome. The enormous variation that characterizes the human genome suggests that the total number of minor H loci is probably large and ensures that all donor/recipient pairs, despite selection for identity at the MHC, will be mismatched for many minor H antigens. In addition to mismatch at minor H loci, unrelated donor/recipient pairs exhibit genetic disparity at numerous loci within the MHC, particularly HLA-DP, despite selection for identity at HLA-A, -B, -C, and -DRB1. Disparity at HLA-DP exists in 80% of unrelated pairs and clearly influences the outcome of unrelated hematopoietic cell transplantation; the magnitude of this effect probably exceeds that associated with disparity at any locus outside the MHC.

Entities:  

Mesh:

Year:  2012        PMID: 22859606      PMCID: PMC3466963          DOI: 10.1182/blood-2012-04-347286

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  108 in total

Review 1.  Origin and plasticity of MHC I-associated self peptides.

Authors:  Danielle de Verteuil; Diana Paola Granados; Pierre Thibault; Claude Perreault
Journal:  Autoimmun Rev       Date:  2011-11-12       Impact factor: 9.754

Review 2.  Evaluation of published single nucleotide polymorphisms associated with acute GVHD.

Authors:  Jason W Chien; Xinyi Cindy Zhang; Wenhong Fan; Hongwei Wang; Lue Ping Zhao; Paul J Martin; Barry E Storer; Michael Boeckh; Edus H Warren; John A Hansen
Journal:  Blood       Date:  2012-01-26       Impact factor: 22.113

3.  Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro.

Authors:  Caroline E Rutten; Simone A P van Luxemburg-Heijs; Edith D van der Meijden; Marieke Griffioen; Machteld Oudshoorn; Roel Willemze; J H Frederik Falkenburg
Journal:  Blood       Date:  2010-01-07       Impact factor: 22.113

4.  Deep sequencing of the human TCRγ and TCRβ repertoires suggests that TCRβ rearranges after αβ and γδ T cell commitment.

Authors:  Anna M Sherwood; Cindy Desmarais; Robert J Livingston; Jessica Andriesen; Maximilian Haussler; Christopher S Carlson; Harlan Robins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

5.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Authors:  Katharina Fleischhauer; Bronwen E Shaw; Theodore Gooley; Mari Malkki; Peter Bardy; Jean-Denis Bignon; Valérie Dubois; Mary M Horowitz; J Alejandro Madrigal; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Stephen Spellman; Andrea Velardi; Elisabetta Zino; Effie W Petersdorf
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

6.  Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.

Authors:  Fabrice Porcheray; David B Miklos; Blair H Floyd; Stefanie Sarantopoulos; Roberto Bellucci; Robert J Soiffer; Joseph H Antin; Edwin P Alyea; Jerome Ritz; Emmanuel Zorn
Journal:  Transplantation       Date:  2011-08-15       Impact factor: 4.939

7.  Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.

Authors:  Marieke Griffioen; M Willy Honders; Edith D van der Meijden; Simone A P van Luxemburg-Heijs; Ellie G A Lurvink; Michel G D Kester; Cornelis A M van Bergen; J H Frederik Falkenburg
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

8.  Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.

Authors:  Yishai Ofran; Haesook T Kim; Vladimir Brusic; Loren Blake; Michael Mandrell; Catherine J Wu; Stefanie Sarantopoulos; Roberto Bellucci; Derin B Keskin; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Clin Cancer Res       Date:  2010-02-16       Impact factor: 12.531

9.  A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR.

Authors:  Kelly Broen; Henriette Levenga; Johanna Vos; Kees van Bergen; Hanny Fredrix; Annelies Greupink-Draaisma; Michel Kester; J H Frederik Falkenburg; Pieter de Mulder; Theo de Witte; Marieke Griffioen; Harry Dolstra
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

10.  Detection of structural variants and indels within exome data.

Authors:  Emre Karakoc; Can Alkan; Brian J O'Roak; Megan Y Dennis; Laura Vives; Kenneth Mark; Mark J Rieder; Debbie A Nickerson; Evan E Eichler
Journal:  Nat Methods       Date:  2011-12-18       Impact factor: 28.547

View more
  42 in total

1.  Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients.

Authors:  Yoshihiro Inamoto; Jennifer White; Reiko Ito; Paul J Martin; Giancarlo Fatobene; Ayumu Ito; Takashi Tanaka; Saiko Kurosawa; Sung-Won Kim; Merav Bar; Mohamed L Sorror; Brenda M Sandmaier; Stephanie J Lee; Takahiro Fukuda; Mary E D Flowers
Journal:  Blood Adv       Date:  2019-09-24

2.  LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application.

Authors:  Margot J Pont; Willemijn Hobo; Maria W Honders; Simone A P van Luxemburg-Heijs; Michel G D Kester; Annemarie M van Oeveren-Rietdijk; Nicolaas Schaap; Hetty C de Boer; Cornelis A M van Bergen; Harry Dolstra; J H Frederik Falkenburg; Marieke Griffioen
Journal:  Haematologica       Date:  2015-06-11       Impact factor: 9.941

3.  Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.

Authors:  Marcelo A Fernandez-Viña; Tao Wang; Stephanie J Lee; Michael Haagenson; Mahmoud Aljurf; Medhat Askar; Minoo Battiwalla; Lee-Ann Baxter-Lowe; James Gajewski; Ann A Jakubowski; Susana Marino; Machteld Oudshoorn; Steven G E Marsh; Effie W Petersdorf; Kirk Schultz; E Victoria Turner; Edmund K Waller; Ann Woolfrey; John Umejiego; Stephen R Spellman; Michelle Setterholm
Journal:  Blood       Date:  2014-01-09       Impact factor: 22.113

4.  BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.

Authors:  Hideki Nakasone; Koji Kawamura; Kimikazu Yakushijin; Akihito Shinohara; Masatsugu Tanaka; Kazuteru Ohashi; Shuichi Ota; Naoyuki Uchida; Takahiro Fukuda; Hirohisa Nakamae; Ken-Ichi Matsuoka; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshihiro Inamoto; Sachiko Seo; Fumihiko Kimura; Masao Ogata
Journal:  Blood Adv       Date:  2019-06-11

5.  Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.

Authors:  Paul J Martin; David M Levine; Barry E Storer; Edus H Warren; Xiuwen Zheng; Sarah C Nelson; Anajane G Smith; Bo K Mortensen; John A Hansen
Journal:  Blood       Date:  2016-11-21       Impact factor: 22.113

6.  Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population.

Authors:  Derek James Pappas; Pierre-Antoine Gourraud; Caroline Le Gall; Julie Laurent; Alan Trounson; Natalie DeWitt; Sohel Talib
Journal:  Stem Cells Transl Med       Date:  2015-05       Impact factor: 6.940

Review 7.  Making the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantation.

Authors:  Yun R Li; John E Levine; Hakon Hakonarson; Brendan J Keating
Journal:  Eur J Hum Genet       Date:  2013-11-20       Impact factor: 4.246

8.  Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.

Authors:  Anandharaman Veerapathran; Joseph Pidala; Francisca Beato; Brian Betts; Jongphil Kim; Joel G Turner; Marc K Hellerstein; Xue-Zhong Yu; William Janssen; Claudio Anasetti
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

9.  Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.

Authors:  Raphael Carapito; Ismail Aouadi; Angélique Pichot; Perrine Spinnhirny; Aurore Morlon; Irina Kotova; Cécile Macquin; Véronique Rolli; Anne Cesbron; Katia Gagne; Machteld Oudshoorn; Bronno van der Holt; Myriam Labalette; Eric Spierings; Christophe Picard; Pascale Loiseau; Ryad Tamouza; Antoine Toubert; Anne Parissiadis; Valérie Dubois; Catherine Paillard; Myriam Maumy-Bertrand; Frédéric Bertrand; Peter A von dem Borne; Jürgen H E Kuball; Mauricette Michallet; Bruno Lioure; Régis Peffault de Latour; Didier Blaise; Jan J Cornelissen; Ibrahim Yakoub-Agha; Frans Claas; Philippe Moreau; Dominique Charron; Mohamad Mohty; Yasuo Morishima; Gérard Socié; Seiamak Bahram
Journal:  Bone Marrow Transplant       Date:  2020-04-14       Impact factor: 5.483

10.  Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Authors:  Hideki Nakasone; Mats Remberger; Lu Tian; Petter Brodin; Bita Sahaf; Fang Wu; Jonas Mattsson; Robert Lowsky; Robert Negrin; David B Miklos; Everett Meyer
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.